• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

E2012 Inhibitor – E 2012

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5754811

E 2012 is a potent modulator of gamma gamma secretase without affecting Notch processing. E 2012 inhibits 3beta-hydroxysterol delta24-reductase at the final step in the cholesterol biosynthesis. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
E 2012 (E2012), Inhibitor
Full Product Name
E 2012
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
419.49
Solubility
DMSO: 50mg/mL (119.19mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C25H26FN3O2
SMILES
O=C(N([C@H](C1=CC=C(C=C1)F)C)CCC/2)C2=C\C3=CC=C(N4C=NC(C)=C4)C(OC)=C3
CAS Number
870843-42-8
Target & IC50
Others
In Vitro
Lenticular concentration of E 2012 after 13-week repeated-dose with cataract was well above those where inhibition is observed in vitro. E 2012 induces cataract in the rat by inhibiting DHCR24 at the final step of cholesterol synthesis with associated elevation in desmosterol within the lens. After preceded by desmosterol changes that would serve as a predictive safety biomarker for lenticular opacity [2].

Structure of E2012, inhibitor

E2012 Inhibitor – Cat# MBS5754811

Product References and Citations for E2012, inhibitor

Nakano-Ito K, et al. E2012-induced cataract and its predictive biomarkers. Toxicol Sci. 2014 Jan;137(1):249-58.
Nakano-Ito K, et al. E2012-induced cataract and its predictive biomarkers. Toxicol Sci. 2014 Jan;137(1):249-58.
Portelius E, Van Broeck B, Andreasson U, Gustavsson MK, Mercken M, Zetterberg H, Borghys H, Blennow K. Acute effect on the Abeta isoform pattern in CSF in response to gamma-secretase modulator and inhibitor treatment,in dogs.J Alzheimers Dis. 2010;21(3):1005-12.
Portelius E, Van Broeck B, Andreasson U, Gustavsson MK, Mercken M, Zetterberg H, Borghys H, Blennow K. Acute effect on the Abeta isoform pattern in CSF in response to gamma-secretase modulator and inhibitor treatment,in dogs.J Alzheimers Dis. 2010;21(3):1005-12.

Other Notes

Small volumes of E2012, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for E2012 purchase

MBS5754811 is an inhibitor targeting E2012. Also known as E 2012.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000